taxonomy (7)
protein (187)
source (22)
structure (20)
composition (1)
disease (6)
reference (28)
site (270)
peptide (290)
- Homo sapiens (Human)
- Bos taurus (Bovine)
- Mus musculus (House mouse)
- Sus scrofa (Pig)
- Torpedo californica (Pacific electric ray)
- Friend murine leukemia virus (F-mulv)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- Acid ceramidase / Homo sapiens Q13510
- Adhesion G protein-coupled receptor F5 / Homo sapiens Q8IZF2
- Adipocyte enhancer-binding protein 1 / Homo sapiens Q8IUX7
- Afamin / Homo sapiens P43652
- Agrin / Homo sapiens O00468
- Alpha-1-acid glycoprotein 1 / Homo sapiens P02763
- Alpha-1-acid glycoprotein 2 / Homo sapiens P19652
- Alpha-1-antichymotrypsin / Homo sapiens P01011
- Alpha-1-antitrypsin / Homo sapiens P01009
- Alpha-2-HS-glycoprotein / Homo sapiens P02765
- Alpha-2-macroglobulin / Homo sapiens P01023
- Alpha-S1-casein / Homo sapiens P47710
- Aminopeptidase n / Homo sapiens P15144
- Angiopoietin-related protein 2 / Homo sapiens Q9UKU9
- Angiotensin-converting enzyme / Homo sapiens P12821
- Anoctamin-6 / Homo sapiens Q4KMQ2
- Antithrombin-III / Homo sapiens P01008
- Apolipoprotein (a) / Homo sapiens P08519
- Apolipoprotein B-100 / Homo sapiens P04114
- Apolipoprotein D / Homo sapiens P05090
- Asialoglycoprotein receptor 2 / Homo sapiens P07307
- Attractin / Homo sapiens O75882
- Basement membrane-specific heparan sulfate proteoglycan core protein / Homo sapiens P98160
- Beta-2-glycoprotein 1 / Homo sapiens P02749
- Biglycan / Homo sapiens P21810
- Bone morphogenetic protein 1 / Homo sapiens P13497
- BRCA2-interacting transcriptional repressor EMSY / Homo sapiens Q7Z589
- C-type mannose receptor 2 / Homo sapiens Q9UBG0
- C4b-binding protein alpha chain / Homo sapiens P04003
- C4b-binding protein beta chain / Homo sapiens P20851
- Cadherin-13 / Homo sapiens P55290
- Calumenin / Homo sapiens O43852
- Carboxypeptidase D / Homo sapiens O75976
- CD166 antigen / Homo sapiens Q13740
- CD276 antigen / Homo sapiens Q5ZPR3
- CD44 antigen / Homo sapiens P16070
- CD59 glycoprotein / Homo sapiens P13987
- Ceruloplasmin / Homo sapiens P00450
- Clusterin / Homo sapiens P10909
- Collagen alpha-1(VI) chain / Homo sapiens P12109
- Collagen alpha-1(XII) chain / Homo sapiens Q99715
- Collagen alpha-2(VI) chain / Homo sapiens P12110
- Collagen alpha-3(VI) chain / Homo sapiens P12111
- Complement C2 / Homo sapiens P06681
- Complement c4-a / Homo sapiens P0C0L4
- Complement C4-B / Homo sapiens P0C0L5
- Complement component C9 / Homo sapiens P02748
- Complement factor b / Homo sapiens P00751
- Complement factor h / Homo sapiens P08603
- Complement factor H-related protein 1 / Homo sapiens Q03591
- Complement factor H-related protein 2 / Homo sapiens P36980
- Complement factor H-related protein 4 / Homo sapiens Q92496
- Complement factor i / Homo sapiens P05156
- Complement receptor type 1 / Homo sapiens P17927
- Contactin-4 / Homo sapiens Q8IWV2
- Corticosteroid-binding globulin / Homo sapiens P08185
- Decorin / Homo sapiens P07585
- Desmocollin-2 / Homo sapiens Q02487
- Desmoglein-2 / Homo sapiens Q14126
- Disintegrin and metalloproteinase domain-containing protein 15 / Homo sapiens Q13444
- Ectonucleoside triphosphate diphosphohydrolase 2 / Homo sapiens Q9Y5L3
- Endoplasmic reticulum aminopeptidase 2 / Homo sapiens Q6P179
- Ephrin-A3 / Homo sapiens P52797
- Ephrin-B2 / Homo sapiens P52799
- Epidermal growth factor receptor / Homo sapiens P00533
- Epithelial cell adhesion molecule / Homo sapiens P16422
- Extracellular matrix protein 1 / Homo sapiens Q16610
- Fetuin-B / Homo sapiens Q9UGM5
- Fibrillin-1 / Homo sapiens P35555
- Fibrinogen beta chain / Homo sapiens P02675
- Fibromodulin / Homo sapiens Q06828
- Fibronectin / Homo sapiens P02751
- Golgi apparatus protein 1 / Homo sapiens Q92896
- Haptoglobin / Homo sapiens P00738
- Heat shock 70 kDa protein 1-like / Homo sapiens P34931
- Heat shock 70 kDa protein 1A / Homo sapiens P0DMV8
- Heat shock 70 kDa protein 1B / Homo sapiens P0DMV9
- Hemopexin / Homo sapiens P02790
- Heparin cofactor 2 / Homo sapiens P05546
- Histidine-rich glycoprotein / Homo sapiens P04196
- Homeobox protein Hox-B3 / Homo sapiens P14651
- IgGFc-binding protein / Homo sapiens Q9Y6R7
- Immunoglobulin heavy constant alpha 2 / Homo sapiens P01877
- Immunoglobulin heavy constant delta / Homo sapiens P01880
- Immunoglobulin heavy constant gamma 4 / Homo sapiens P01861
- Immunoglobulin heavy constant mu / Homo sapiens P01871
- Immunoglobulin J chain / Homo sapiens P01591
- Immunoglobulin superfamily containing leucine-rich repeat protein / Homo sapiens O14498
- Immunoglobulin superfamily DCC subclass member 4 / Homo sapiens Q8TDY8
- Immunoglobulin superfamily member 8 / Homo sapiens Q969P0
- Inactive carboxypeptidase-like protein X2 / Homo sapiens Q8N436
- Inactive tyrosine-protein kinase 7 / Homo sapiens Q13308
- Inter-alpha-trypsin inhibitor heavy chain h1 / Homo sapiens P19827
- Inter-alpha-trypsin inhibitor heavy chain h2 / Homo sapiens P19823
- Inter-alpha-trypsin inhibitor heavy chain H3 / Homo sapiens Q06033
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens Q14624
- Inter-alpha-trypsin inhibitor heavy chain H5 / Homo sapiens Q86UX2
- Intercellular adhesion molecule 2 / Homo sapiens P13598
- Interleukin-1 receptor-like 1 / Homo sapiens Q01638
- Interleukin-6 receptor subunit beta / Homo sapiens P40189
- Kallistatin / Homo sapiens P29622
- Kininogen-1 / Homo sapiens P01042
- Lactotransferrin / Homo sapiens P02788
- Laminin subunit alpha-2 / Homo sapiens P24043
- Laminin subunit alpha-4 / Homo sapiens Q16363
- Laminin subunit gamma-1 / Homo sapiens P11047
- Latent transforming growth factor beta binding protein 1 / Homo sapiens Q14766
- Leucine-rich alpha-2-glycoprotein / Homo sapiens P02750
- Low affinity immunoglobulin gamma Fc region receptor III-A (FcγRIIIa ) / Homo sapiens P08637
- Low affinity immunoglobulin gamma Fc region receptor III-B / Homo sapiens O75015
- Lumican / Homo sapiens P51884
- Lysosome membrane protein 2 / Homo sapiens Q14108
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens P11279
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens P13473
- Macrophage mannose receptor 1 / Homo sapiens P22897
- Macrosialin / Homo sapiens P34810
- Mesothelin / Homo sapiens Q13421
- Midasin / Homo sapiens Q9NU22
- Myelin protein P0 / Homo sapiens P25189
- Myelin protein zero-like protein 1 / Homo sapiens O95297
- N-acetylglucosamine-1-phosphotransferase subunits alpha/beta / Homo sapiens Q3T906
- N-acetylmuramoyl-l-alanine amidase / Homo sapiens Q96PD5
- Neogenin / Homo sapiens Q92859
- Neural cell adhesion molecule 1 / Homo sapiens P13591
- Neurofascin / Homo sapiens O94856
- Neuronal cell adhesion molecule / Homo sapiens Q92823
- Olfactomedin-like protein 3 / Homo sapiens Q9NRN5
- Periostin / Homo sapiens Q15063
- Plasma kallikrein / Homo sapiens P03952
- Plasma protease c1 inhibitor / Homo sapiens P05155
- Plasma serine protease inhibitor / Homo sapiens P05154
- Plexin-B2 / Homo sapiens O15031
- Podocan / Homo sapiens Q7Z5L7
- Polymeric immunoglobulin receptor / Homo sapiens P01833
- Prolactin-inducible protein / Homo sapiens P12273
- Prolargin / Homo sapiens P51888
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens Q07954
- Prostaglandin F2 receptor negative regulator / Homo sapiens Q9P2B2
- Prostaglandin-h2 d-isomerase / Homo sapiens P41222
- Prostate-specific antigen (psa-1) / Homo sapiens P07288
- Prostate-specific antigen - high Pi isoform (psah) / Homo sapiens P07288
- Protein AMBP / Homo sapiens P02760
- Protocadherin-9 / Homo sapiens Q9HC56
- Receptor-type tyrosine-protein phosphatase C / Homo sapiens P08575
- Receptor-type tyrosine-protein phosphatase F / Homo sapiens P10586
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens Q15262
- Secreted frizzled-related protein 3 / Homo sapiens Q92765
- Selenoprotein P / Homo sapiens P49908
- Semaphorin-6A / Homo sapiens Q9H2E6
- Semaphorin-7A / Homo sapiens O75326
- Serotransferrin / Homo sapiens P02787
- Sex hormone-binding globulin / Homo sapiens P04278
- Signal transducer CD24 / Homo sapiens P25063
- Sparc / Homo sapiens P09486
- Sulfhydryl oxidase 1 / Homo sapiens O00391
- Tenascin / Homo sapiens P24821
- Teneurin-2 / Homo sapiens Q9NT68
- Thrombospondin-1 / Homo sapiens P07996
- Tolloid-like protein 1 / Homo sapiens O43897
- Tolloid-like protein 2 / Homo sapiens Q9Y6L7
- Transmembrane 9 superfamily member 3 / Homo sapiens Q9HD45
- Uromodulin / Homo sapiens P07911
- Vascular cell adhesion protein 1 / Homo sapiens P19320
- Vitronectin / Homo sapiens P04004
- Von willebrand factor / Homo sapiens P04275
- Zinc-alpha-2-glycoprotein / Homo sapiens P25311
- Acetylcholinesterase / Bos taurus P23795
- Ribonuclease, brain / Bos taurus P39873
- Uncharacterized protein / Bos taurus
- Cell adhesion molecule 4 / Mus musculus Q8R464
- Complement C1q subcomponent subunit A / Mus musculus P98086
- Hepatocyte cell adhesion molecule / Mus musculus Q640R3
- Myelin-oligodendrocyte glycoprotein / Mus musculus Q61885
- Neural cell adhesion molecule L1 / Mus musculus P11627
- Probable G-protein coupled receptor 158 / Mus musculus Q8C419
- Protein disulfide-isomerase TMX3 / Mus musculus Q8BXZ1
- Thy-1 membrane glycoprotein / Mus musculus P01831
- Uncharacterized protein from Lung / Mus musculus
- Zona pellucida sperm-binding protein matrix / Mus musculus P10761 P20239 Q62005
- Major seminal plasma glycoprotein psp-i / Sus scrofa P35495
- Major seminal plasma glycoprotein psp-ii / Sus scrofa P35496
- Thyroglobulin / Sus scrofa
- Acetylcholine receptor protein / Torpedo californica P02710 P02714 P02718 P02712
- Envelope glycoprotein / Friend murine leukemia virus P03395
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Blood Serum (UBERON_0001977) Mature NK T cell (CL_0000814)
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Cerebellum (UBERON_0002037)
- Electric Organ (UBERON_0006869)
- Frontal Cortex (UBERON_0001870)
- Hippocampul formation (UBERON:0002421)
- Lung (UBERON_0002048) LL/2 (LLC1) (CVCL_4358)
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Prefrontal Cortex (UBERON:0000451)
- Seminal Fluid (UBERON_0006530)
- Striatum (UBERON_0002345)
- Thyroid (UBERON_0002046)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Urine (UBERON_0001088)
- Zona Pellucida (UBERON_0000086)
- Eveline (CVCL_A1LI)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- EBV-transformed B-cell (CL_0000236)
- Plasma Membrane (GO_0005886)
Source
- Free / Lactose / [[Fuc(a1-2)]Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)][Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)][Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [[Gal(b1-4)GlcNAc(b1-6)][[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)GlcNAc(b1-6)][Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Neu5Ac(a2-6)Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)][[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Neu5Ac(a2-6)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)][[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / Structure 9196
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc"
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-?)[NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
- N-Linked / Complex / Gal(b1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Hybrid / Structure 9475
- N-Linked / Hybrid / Structure 10001
- N-Linked / Hybrid / Structure 10132
- N-Linked / Hybrid / Structure 10979
- N-Linked / Hybrid / Structure 11541
- N-Linked / Hybrid / Structure 11553
- N-Linked / Hybrid / Structure 11792
Reported structure
- Cancer, breast (DOID:1612)
- Carcinoma, Lewis Lung
- Control/Healthy
- COVID-19 (DOID:0080600)
- Hyper IgE syndrome (HIES, p.Glu340del) (DOID:0080545)
- Prostate cancer (DOID:10283)
Disease
- Mammalian brain glycoproteins exhibit diminished glycan complexity compared to other tissues (2022 - Williams SE, Noel M, Lehoux S, Cetinbas M, Xavier RJ, Sadreyev RI, Scolnick EM, Smoller JW, Cummings RD, Mealer RG) / Status : Reviewed
- Structural and functional characterization of SARS-CoV-2 RBD domains produced in mammalian cells (2021 - Christoph Gstöttner, Tao Zhang, Anja Resemann, Sophia Ruben, Stuart Pengelley, Detlev Suckau, Tim Welsink, Manfred Wuhrer, Elena Domínguez-Vega) / Status : Reviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Increasing the Coverage of a Mass Spectral Library of Milk Oligosaccharides Using a Hybrid-Search-Based Bootstrapping Method and Milks from a Wide Variety of Mammals (2020 - Concepcion Africano Remoroza, Yuxue Liang, Tytus D. Mak, Yuri Mirokhin, Sergey L. Sheetlin, Xiaoyu Yang, Joice V. San Andres, Michael L. Power, and Stephen E. Stein) / Status : Reviewed
- Quantitative Longitudinal Inventory of the N-Glycoproteome of Human Milk from a Single Donor Reveals the Highly Variable Repertoire and Dynamic Site-Specific Changes (2020 - Jing Zhu, Yu-Hsien Lin, Kelly A Dingess, Marko Mank, Bernd Stahl, Albert J R Heck) / Status : Reviewed
- Spatial and temporal diversity of glycome expression in mammalian brain (2020 - Lee J, Ha S, Kim M, Kim SW, Yun J, Ozcan S, Hwang H, Ji IJ, Yin D, Webster MJ, Shannon Weickert C, Kim JH, Yoo JS, Grimm R, Bahn S, Shin HS, An HJ) / Status : Reviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Primary Human Natural Killer Cells Retain Proinflammatory IgG1 at the Cell Surface and Express CD16a Glycoforms with Donor-dependent Variability. (2019 - Patel KR, Nott JD, Barb AW) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Synthesis of Asymmetrical Multiantennary Human Milk Oligosaccharides (2017 - Anthony R Prudden, Lin Liu, Chantelle J Capicciotti, Margreet A Wolfert, Shuo Wang, Zhongwei Gao, Lu Meng, Kelley W Moremen, Geert-Jan Boons) / Status : Reviewed
- Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels, (2014 - Atfa Sassi, Sandra Lazaroski, Gang Wu, Stuart M. Haslam, Manfred Fliegauf, Fethi Mellouli, Turkan Patiroglu, Ekrem Unal, Mehmet Akif Ozdemir, Zineb Jouhadi, Khadija Khadir, Leila Ben-Khemis, Meriem Ben-Ali, Imen Ben-Mustapha, Lamia Borchani, Dietmar Pfeifer, Thilo Jakob, Monia Khemiri, A. Charlotta Asplund, Manuela O. Gustafsson, Karin E. Lundin, Elin Falk-Sörqvist, Lotte N. Moens, Hatice Eke Gungor, Karin R. Engelhardt, Magdalena Dziadzio, Hans Stauss, Bernhard Fleckenstein, Rebecca Meier, Khairunnadiya Prayitno, Andrea Maul-Pavicic, Sandra Schaffer, Mirzokhid Rakhmanov, Philipp Henneke, Helene Kraus, Hermann Eibel, Uwe Kölsch, Sellama Nadifi, Mats Nilsson, Mohamed Bejaoui, Alejandro A. Schäffer, C.I. Edvard Smith, Anne Dell, Mohamed-Ridha Barbouche, Bodo Grimbacher) / Status : Reviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Glycoproteomics: Identifying the Glycosylation of Prostate Specific Antigen at Normal and High Isoelectric Points by LC-MS/MS (2014 - Song E, Mayampurath A, Yu CY, Tang H, Mechref Y) / Status : Reviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Hierarchy of post-translational modifications involved in the circulatory longevity of glycoproteins. Demonstration of concerted contributions of glycan sialylation and subunit assembly to the pharmacokinetic behavior of bovine acetylcholinesterase. (2000 - Kronman C, Chitlaru T, Elhanany E, Velan B, Shafferman A) / Status : Reviewed
- Structural analysis of murine zona pellucida glycans. Evidence for the expression of core 2-type O-glycans and the Sd(a) antigen. (2000 - Easton RL, Patankar MS, Lattanzio FA, Leaven TH, Morris HR, Clark GF, Dell A) / Status : Reviewed
- Structural characterization of the oligosaccharide chains of native and crystallized boar seminal plasma spermadhesin PSP-I and PSP-II glycoforms. (1999 - Nimtz M, Grabenhorst E, Conradt H, Sanz L, Calvete J) / Status : Reviewed
- Detailed structural analysis of asparagine-linked oligosaccharides of the nicotinic acetylcholine receptor from Torpedo californica. (1992 - Shoji H, Takahashi N, Nomoto H, Ishikawa M, Shimada I, Arata Y, Hayashi K) / Status : Reviewed
- Structure determination by 1H NMR spectroscopy of (sulfated) sialylated N-linked carbohydrate chains released from porcine thyroglobulin by peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase-F. (1991 - de Waard P, Koorevaar A, Kamerling J, Vliegenthart J) / Status : Reviewed
- Structures of the alpha(1-3)-galactose-containing asparagine-linked glycans of a Lewis lung carcinoma cell subline resistant to Aleuria aurantia agglutinin: elucidation by 1H-NMR spectroscopy. (1991 - Debray H, Dus D, Wieruszeski J, Strecker G, Montreuil J) / Status : Reviewed
- Oligosaccharides at individual glycosylation sites in glycoprotein 71 of Friend murine leukemia virus. (1990 - Geyer R, Dabrowski J, Dabrowski U, Linder D, Schlter M, Schott H, Stirm S) / Status : Reviewed
- The structure of the asparagine-linked sugar chains of bovine brain ribonuclease. (1990 - Katoh H, Ohgi K, Irie M, Endo T, Kobata A) / Status : Reviewed
- Analysis of N- and O-glycosidically bound sialooligosaccharides in glycoproteins by high-performance liquid chromatography with pulsed amperometric detection. (1990 - Honda S, Suzuki S, Zaiki S, Kakehi K) / Status : Reviewed
- Primary structure of the N-glycosidically linked sialoglycans of secretory immunoglobulins A from human milk. (1982 - Pierce-Cretel A, Pamblanco M, Strecker G, Montreuil J, Spik G, Dorland L, Van Halbeek H, Vliegenthart J) / Status : Reviewed
- The asparagine-linked sugar chains of the glycoproteins in calf thymocyte plasma membrane. Structural studies of acidic oligosaccharides. (1980 - Yoshima H, Takasaki S, Kobata A) / Status : Reviewed
Reference
- Acid ceramidase / Homo sapiens
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- Adipocyte enhancer-binding protein 1 / Homo sapiens
- Afamin / Homo sapiens
- Agrin / Homo sapiens
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-acid glycoprotein 2 / Homo sapiens
- Alpha-1-antichymotrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-2-HS-glycoprotein / Homo sapiens
- Alpha-2-macroglobulin / Homo sapiens
- Alpha-S1-casein / Homo sapiens
- Aminopeptidase n / Homo sapiens
- Angiopoietin-related protein 2 / Homo sapiens
- Angiotensin-converting enzyme / Homo sapiens
- Anoctamin-6 / Homo sapiens
- Antithrombin-III / Homo sapiens
- Apolipoprotein (a) / Homo sapiens
- Apolipoprotein B-100 / Homo sapiens
- Apolipoprotein D / Homo sapiens
- Asialoglycoprotein receptor 2 / Homo sapiens
- Attractin / Homo sapiens
- Basement membrane-specific heparan sulfate proteoglycan core protein / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Biglycan / Homo sapiens
- Bone morphogenetic protein 1 / Homo sapiens
- BRCA2-interacting transcriptional repressor EMSY / Homo sapiens
- C-type mannose receptor 2 / Homo sapiens
- C4b-binding protein alpha chain / Homo sapiens
- C4b-binding protein beta chain / Homo sapiens
- Cadherin-13 / Homo sapiens
- Calumenin / Homo sapiens
- Carboxypeptidase D / Homo sapiens
- CD166 antigen / Homo sapiens
- CD276 antigen / Homo sapiens
- CD44 antigen / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Clusterin / Homo sapiens
- Collagen alpha-1(VI) chain / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-2(VI) chain / Homo sapiens
- Collagen alpha-3(VI) chain / Homo sapiens
- Complement C2 / Homo sapiens
- Complement c4-a / Homo sapiens
- Complement C4-B / Homo sapiens
- Complement component C9 / Homo sapiens
- Complement factor b / Homo sapiens
- Complement factor h / Homo sapiens
- Complement factor H-related protein 1 / Homo sapiens
- Complement factor H-related protein 2 / Homo sapiens
- Complement factor H-related protein 4 / Homo sapiens
- Complement factor i / Homo sapiens
- Complement receptor type 1 / Homo sapiens
- Contactin-4 / Homo sapiens
- Corticosteroid-binding globulin / Homo sapiens
- Decorin / Homo sapiens
- Desmocollin-2 / Homo sapiens
- Desmoglein-2 / Homo sapiens
- Disintegrin and metalloproteinase domain-containing protein 15 / Homo sapiens
- Ectonucleoside triphosphate diphosphohydrolase 2 / Homo sapiens
- Endoplasmic reticulum aminopeptidase 2 / Homo sapiens
- Ephrin-A3 / Homo sapiens
- Ephrin-B2 / Homo sapiens
- Epidermal growth factor receptor / Homo sapiens
- Epithelial cell adhesion molecule / Homo sapiens
- Extracellular matrix protein 1 / Homo sapiens
- Fetuin-B / Homo sapiens
- Fibrillin-1 / Homo sapiens
- Fibrinogen beta chain / Homo sapiens
- Fibromodulin / Homo sapiens
- Fibronectin / Homo sapiens
- Golgi apparatus protein 1 / Homo sapiens
- Haptoglobin / Homo sapiens
- Heat shock 70 kDa protein 1-like / Homo sapiens
- Heat shock 70 kDa protein 1A / Homo sapiens
- Heat shock 70 kDa protein 1B / Homo sapiens
- Hemopexin / Homo sapiens
- Heparin cofactor 2 / Homo sapiens
- Histidine-rich glycoprotein / Homo sapiens
- Homeobox protein Hox-B3 / Homo sapiens
- IgGFc-binding protein / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Immunoglobulin heavy constant delta / Homo sapiens
- Immunoglobulin heavy constant gamma 4 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Immunoglobulin J chain / Homo sapiens
- Immunoglobulin superfamily containing leucine-rich repeat protein / Homo sapiens
- Immunoglobulin superfamily DCC subclass member 4 / Homo sapiens
- Immunoglobulin superfamily member 8 / Homo sapiens
- Inactive carboxypeptidase-like protein X2 / Homo sapiens
- Inactive tyrosine-protein kinase 7 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h1 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h2 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain H3 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain H5 / Homo sapiens
- Intercellular adhesion molecule 2 / Homo sapiens
- Interleukin-1 receptor-like 1 / Homo sapiens
- Interleukin-6 receptor subunit beta / Homo sapiens
- Kallistatin / Homo sapiens
- Kininogen-1 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Laminin subunit alpha-2 / Homo sapiens
- Laminin subunit alpha-4 / Homo sapiens
- Laminin subunit gamma-1 / Homo sapiens
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- Low affinity immunoglobulin gamma Fc region receptor III-A (FcγRIIIa ) / Homo sapiens
- Low affinity immunoglobulin gamma Fc region receptor III-B / Homo sapiens
- Lumican / Homo sapiens
- Lysosome membrane protein 2 / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Macrophage mannose receptor 1 / Homo sapiens
- Macrosialin / Homo sapiens
- Mesothelin / Homo sapiens
- Midasin / Homo sapiens
- Myelin protein P0 / Homo sapiens
- Myelin protein zero-like protein 1 / Homo sapiens
- N-acetylglucosamine-1-phosphotransferase subunits alpha/beta / Homo sapiens
- N-acetylmuramoyl-l-alanine amidase / Homo sapiens
- Neogenin / Homo sapiens
- Neural cell adhesion molecule 1 / Homo sapiens
- Neurofascin / Homo sapiens
- Neuronal cell adhesion molecule / Homo sapiens
- Olfactomedin-like protein 3 / Homo sapiens
- Periostin / Homo sapiens
- Plasma kallikrein / Homo sapiens
- Plasma protease c1 inhibitor / Homo sapiens
- Plasma serine protease inhibitor / Homo sapiens
- Plexin-B2 / Homo sapiens
- Podocan / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prolargin / Homo sapiens
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
- Prostaglandin F2 receptor negative regulator / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Prostate-specific antigen (psa-1) / Homo sapiens
- Prostate-specific antigen - high Pi isoform (psah) / Homo sapiens
- Protein AMBP / Homo sapiens
- Protocadherin-9 / Homo sapiens
- Receptor-type tyrosine-protein phosphatase C / Homo sapiens
- Receptor-type tyrosine-protein phosphatase F / Homo sapiens
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens
- Secreted frizzled-related protein 3 / Homo sapiens
- Selenoprotein P / Homo sapiens
- Semaphorin-6A / Homo sapiens
- Semaphorin-7A / Homo sapiens
- Serotransferrin / Homo sapiens
- Sex hormone-binding globulin / Homo sapiens
- Signal transducer CD24 / Homo sapiens
- Sparc / Homo sapiens
- Sulfhydryl oxidase 1 / Homo sapiens
- Tenascin / Homo sapiens
- Teneurin-2 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Tolloid-like protein 1 / Homo sapiens
- Tolloid-like protein 2 / Homo sapiens
- Transmembrane 9 superfamily member 3 / Homo sapiens
- Uromodulin / Homo sapiens
- Vascular cell adhesion protein 1 / Homo sapiens
- Vitronectin / Homo sapiens
- Von willebrand factor / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
-
Acetylcholinesterase / Bos taurus
- Undefined site
- Ribonuclease, brain / Bos taurus
-
Uncharacterized protein / Bos taurus
- Undefined site
- Cell adhesion molecule 4 / Mus musculus
- Complement C1q subcomponent subunit A / Mus musculus
- Hepatocyte cell adhesion molecule / Mus musculus
- Myelin-oligodendrocyte glycoprotein / Mus musculus
- Neural cell adhesion molecule L1 / Mus musculus
- Probable G-protein coupled receptor 158 / Mus musculus
- Protein disulfide-isomerase TMX3 / Mus musculus
- Thy-1 membrane glycoprotein / Mus musculus
-
Uncharacterized protein from Lung / Mus musculus
- Undefined site
-
Zona pellucida sperm-binding protein matrix / Mus musculus
- Undefined site
- Major seminal plasma glycoprotein psp-i / Sus scrofa
- Major seminal plasma glycoprotein psp-ii / Sus scrofa
-
Thyroglobulin / Sus scrofa
- Undefined site
-
Acetylcholine receptor protein / Torpedo californica
- Undefined site
- Envelope glycoprotein / Friend murine leukemia virus
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- DIENFNSTQK (10aa)
- LVPVPITNATLDQITGK (17aa)
- SIVLEPIYWNSSNSK (15aa)
- GCNDSDVLAVAGFALR (16aa)
- TAVNCSSDFDACLITK (16aa)
- TAVNCSSDFDACIITK (16aa)
- GSLEVNCSTTCNQPEVGGLETSLDK (25aa)
- SLPWNMTK (8aa)
- EIFVANGTQGK (11aa)
- WFSAGLASNSSWLR (14aa)
- APNPTNATTK (10aa)
- GCVLLSYLNETVTVSASLESVR (22aa)
- AFNSTLPTMAQMEK (14aa)
- ISPGKNATGMEVGWYR (16aa)
- FHNESLISSQASSY (14aa)
- IADAHIDRVENTTVYYIVIDVQESDCSVISR (31aa)
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- LNGTDVDTGMDFR (13aa)
- CIQANYSIMENGK (13aa)
- QTLFFNGTR (9aa)
- NKSVLLGR (8aa)
- KDTRNESTQNCVVAEPEKM (19aa)
- ENISDPTSPLR (11aa)
- SVQEIQATFFYFTPNKTEDTIFLR (24aa)
- SVQEIQATFFYFTPNK (16aa)
- AEMNGSK (7aa)
- TTENYPNAGLIMNYCR (16aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- AFITNFSMIIDGMTYPGIIK (20aa)
- AFITNF (6aa)
- AFITNFSMNIDGMTYPGIIK (20aa)
- ATVNDSGEYR (10aa)
- SSCGKENTSDPSIVIAFGR (19aa)
- TAFITNFTLTIDGVTYPGNVK (21aa)
- INISENYTISISNAR (15aa)
- VTVRPGESVMVNISAK (16aa)
- VLTLANFTTK (10aa)
- AQLLQGLGFNLTER (14aa)
- AQIIQGIGFNITER (14aa)
- IGHCPDPVIVNGEFSSSGPVNVSDK (25aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- TCNASQGFK (9aa)
- IAVQFGPGFSWIANFTK (17aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- TALFPDLLAQGNASLR (16aa)
- TFYWDFYTNR (10aa)
- ANIQFGDNGTTISAVSNK (18aa)
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- VCSNDNK (7aa)
- GAFISNFSMTVDGK (14aa)
- DLEITNATLQSEEDSR (16aa)
- DGSIVIHNLDYSDNGTFTCDVK (22aa)
- TQSLLIVNNATNVVIK (16aa)
- VIDFNCTTSSVSSALANTK (19aa)
- VIDFNCTTSSVSSAIANTK (19aa)
- LQNNENNISCVER (13aa)
- IQNNENNISCVER (13aa)
- GVNFNVSK (8aa)
- KLHINHNNLTESVGPLPK (18aa)
- LHINHNNLTESVGPLPK (17aa)
- TLNQSSDELQLSMGNAMFVK (20aa)
- TINQSSDEIQISMGNAMFVK (20aa)
- IGACNDTIQQIMEVFK (16aa)
- FGCEIENNR (9aa)
- LGACNDTLQQLMEVFK (16aa)
- NATYGYVIDDPDPDDGFNYK (20aa)
- GLSFDVSLEVSQGPGLLNDTK (21aa)
- EHEGAIYPDNTTDFQR (16aa)
- GTFTDCALANMTEQIR (16aa)
- QIEEFINQSSPFY (13aa)
- QLEEFLNQSSPF (12aa)
- VLTNQESPYQNHTGR (15aa)
- QQYNALLSNMSR (12aa)
- VCQDCPIIAPINDTR (15aa)
- KVCQDCPLLAPLNDTR (16aa)
- KVCQDCPLLAPLNDTRV (17aa)
- RRTAGWNVPIGTLRPFLNWTGPPEPIEAAVARF (33aa)
- VCQDCPLLAPLNDTR (15aa)
- FINDTMAVYEAK (12aa)
- VYKPSAGNNSLYR (13aa)
- ILNQTADMLQLASK (14aa)
- LNLTTDPK (8aa)
- IYIDHNNITR (10aa)
- QQLQGVNVCGGR (12aa)
- HGIQYFNNNTQHSSLFTLNEVK (22aa)
- FVACQMELLHSNGSQR (16aa)
- VIGGNFTGSQR (11aa)
- CGNCSLTTLK (10aa)
- IVDVNITSEGK (11aa)
- AALAAFNAQNNGSNFQLEEISR (22aa)
- IYVIDGTQNDTAFVFPR (17aa)
- INATDADEPNTINSK (15aa)
- MVSHHNITTGATIINEQWIITTAK (24aa)
- MVSHHNLTTGATLINEQWLLTTAK (24aa)
- QVLFLDTVYGNCSTHFTVK (19aa)
- QIGLYPVLVIDSSGYVNPNYTGR (23aa)
- KQIGLYPVLVIDSSGYVNPNYTGRI (25aa)
- LPPGLLANFTLLR (13aa)
- SWPAVGNCSSAL (12aa)
- SWPAVGNCSSALR (13aa)
- SWPAVGNCSSAIR (13aa)
- SLTFNETYQDISELVYGAK (19aa)
- DFVNASSK (8aa)
- DGKPLLNDSR (10aa)
- FIHNENGANYSVTATR (16aa)
- AWGISVLNPNK (11aa)
- VPNNAIEGIENITAIYIQHNEIQEVGSSMR (30aa)
- ITYSIVQTNCSK (12aa)
- GITFQQNASSMCVPDQDTAIR (21aa)
- GLTFQQNASSMCVPDQDTAIR (21aa)
- GNITEYQCHQYITK (14aa)
- IADTNITSIPQGIPPSITEIHIDGNK (26aa)
- NTTGFK (6aa)
- FSIIGHASISCTVENETIGVWRPSPPTCEK (30aa)
- VEMANLLNLSER (12aa)
- YANITVDYLYNK (12aa)
- DFQHIINR (8aa)
- VVLHPNYSQVDIGLIK (16aa)
- VVIHPNYSQVDIGIIK (16aa)
- NISDGFDGIPDNVDAALALPAHSYSGR (27aa)
- FEDGVLDPDYPRNISDGFDGIPDNVDAALALPAHSYSGR (39aa)
- NVVNGSSPAIR (11aa)
- FHLANR (6aa)
- GCSSSTSVLLTLDNNVVNGSSPAIR (25aa)
- DPCSNVTCSFGSTCAR (16aa)
- YFYNGTSMACETFQYGGCMGNGNNFVTEK (29aa)
- IGNWSAMPSCK (11aa)
- VLSNNSDANLELINTWVAK (19aa)
- LGNWSAMPSCK (11aa)
- NPEAPLNVSR (10aa)
- IININPNK (8aa)
- LVAIAVIDEKNTSLEHTR (18aa)
- VVGVPYQGNATAIFIIPSEGK (21aa)
- IGISFNSISAVDNGSIANTPHIR (23aa)
- VVGVPYQGNATALFILPSEGK (21aa)
- MIENGSISFIPTIR (14aa)
- YLGNATAI (8aa)
- YIGNATAIFFIPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- KYLGNATAIFFLPDEGKL (18aa)
- ERPPTFLTPEGNASNK (16aa)
- NETYQLFLSYSSK (13aa)
- LNCSVPGDSHFYFNILQAVTDVIR (24aa)
- IVIDPSGSMNIYIVIDGSDSIGASNFTGAK (30aa)
- IVLDPSGSMNIYLVLDGSDSIGASNFTGAKK (31aa)
- IIAPAYFIIGGNQSGEGCVITR (22aa)
- NVSVAEGK (8aa)
- NMTIDGK (7aa)
- LNAENNATFYFK (12aa)
- GFSTQVLLGDVYQSPCTMAQRPQNFNSSAR (30aa)
- INAENNATFYFK (12aa)
- LSSLEYLDLSSNNLSR (16aa)
- ACPLDPATNK (10aa)
- DGFDISGNPWICDQNLSDLYR (21aa)
- NATGDYK (7aa)
- IYPGVDFGGEEINVTFVK (18aa)
- FQAFANGSLLIPDFGK (16aa)
- IIQVVYIHSNNITK (14aa)
- LHSNNITK (8aa)
- INGTQICPN (9aa)
- FPNIT (5aa)
- RFPNIT (6aa)
- CHLNNSECMPIK (12aa)
- VVNEMCPNITR (11aa)
- NISSEEK (7aa)
- VGQLQLSHNLSLVILVPQNLK (21aa)
- MINTSSIIEQINEQFNWVSR (20aa)
- VQPFNVTQGK (10aa)
- AGIQAFFQVQECNK (14aa)
- AGLQAFFQVQECNK (14aa)
- KVSCPIMPCSNATVPDGECCPR (22aa)
- VSCPIMPCSNATVPDGECCPR (21aa)
- NCTSISGDLHILPVAFR (17aa)
- LNITCESSK (9aa)
- NATVVWMK (8aa)
- IEPVHIQIQCMSQEQIAQVAANATK (25aa)
- LEPVHLQLQCMSQEQLAQVAANATK (25aa)
- TLLNASR (7aa)
- LANLTQGEDQYYLR (14aa)
- IANITQGEDQYYIR (14aa)
- GNTTTLISENGHAADTLTATNFR (23aa)
- TSMGLPVATLQQLEAAAVNVCNQTWAQLQAR (31aa)
- ALQAVYSMMSWPDDVPPEGWNR (22aa)
- SHLQNYTVNATK (12aa)
- LDVDQALNR (9aa)
- ANYTILK (7aa)
- GTAGNAIMDGASQIMGENR (19aa)
- YRGTAGNALMDGASQLMGENR (21aa)
- ENITAPGSDSAVFFEQGTTR (20aa)
- ENLTAPGSDSAVFFEQGTTR (20aa)
- RQDVNITVATVPSWIK (16aa)
- AVNITSENLIDDVVSLIR (18aa)
- DPEIEMSGGLVNGSSVTVSCK (21aa)
- NSTIPTK (7aa)
- NYTDCTSEGR (10aa)
- CGIVPVIAENYNK (13aa)
- CGLVPVLAENYNK (13aa)
- CGLVPVLAENYNKSDNCEDTPEAGYFAVAVVK (32aa)
- HIPGLIHNMTAR (12aa)
- AIPQPQNVTSIIGCTH (16aa)
- YVQNGTYTVK (10aa)
- APQHVVNHLPPYTNVSLK (18aa)
- GETASIICNISVR (13aa)
- SIPACVPWSPYLFQPNDTCIVSGWGR (26aa)
- VPGNVTAVLGETLK (14aa)
- NGSAAMCHFTTK (12aa)
- IIISPEENVTITCTAENQIER (21aa)
- GFGVAIVGNYTAALPTEAALR (21aa)
- WNDSPCNQSLPSICK (15aa)
- LQAPLNYTEFQK (12aa)
- LQAPLNYTEFQKPICLPSK (19aa)
- TAGWNIPMGIIFNQTGSCK (19aa)
- RTAGWNIPMGLLFNQTGSCKF (21aa)
- KSCHTAVDRTAGWNIPMGLLFNQTGSCKF (29aa)
- KWNNTGCQALPSQDEGPSKA (20aa)
- FALLMTNCYATPSSNATDPLK (21aa)
- LPTQNITFQTESSVAEQEAEFQSPK (25aa)
- IPTQNITFQTESSVAEQEAEFQSPK (25aa)
- GPDVLTATVSGKLPTQNITFQTESSVAEQEAEFQSPK (37aa)
- FANEYPNITR (10aa)
- ALSQQNVSMDLATFMK (16aa)
- DQCIVDDITYNVNDTFHK (18aa)
- SCVAVTSAQPQNMSR (15aa)
- IYPITWNGSICMR (13aa)
- EQMEVVNMSLSTSADSLTTPR (21aa)
- HEEGHMLNCTCFGQGR (16aa)
- LGYNANTSVLSFQAVCR (17aa)
- NSTLDPGKPEMMK (13aa)
- ANLSSQALQMSLDYGFVTPLTSMSIR (26aa)
- ANISSQAIQMSIDYGFVTPITSMSIR (26aa)
- SPTNTTPHVPAEGPEASRPPK (21aa)
- INGSITSPGWPK (12aa)
- EVNDTLLVNELK (12aa)
- MAEVIGSKLNISR (13aa)
- QQQHLFGSNVTDCSGNFCLFR (21aa)
- QQQHIFGSNVTDCSGNFCIFR (21aa)
- TMFPNLTDVR (10aa)
- ANYNLPIMVTDSGKPPMTNITDLR (24aa)
- VPVTIAINNTIFIIEER (17aa)
- VTINVMDVNDNSPVVISPPSNTSFK (25aa)
- TEEALPEVTPANVSGGGGSK (20aa)
- NDCISAPINSLLQMAK (16aa)
- IETIIINGTDR (11aa)
- IETILLNGTDRK (12aa)
- NESVHPFSPFEVK (13aa)
- NMTLFSDLVAEK (12aa)
- NASLVTYYTSSGEDILIGGLKPFTK (25aa)
- NVTAQICIDK (10aa)
- TVGNQTSTK (9aa)
- ISEENETTCYMGK (13aa)
- HNSSINATTVMPTMPSVPSGCK (22aa)
- QVFPGINYCTSGAYSNASSTDSASYYPITGDTR (33aa)
- QIVENFSPNQTK (12aa)
- IDAPTNIQFVNETDSTVIVR (20aa)
- LDAPTNLQFVNETDSTVLVR (20aa)
- INYSIPTGQWVGVQIPR (17aa)
- MDGASNVTCINSR (13aa)
- NTTSYVLR (8aa)
- MPSQAPTGNFYPQPIINSSMCIEDSR (26aa)
- VVNSTTGPGEHIR (13aa)
- SPYEMFGDEEVMCLNGNWTEPPQCK (25aa)
- NGTHWFV (7aa)
- VLLHHLDVKTNGTGPVR (17aa)
- NSTPQQQK (8aa)
- NISQDLEK (8aa)
- WTPINSSTIIGYR (13aa)
- ANSTESVR (8aa)
- GLNVTLSSTG (10aa)
- VSNQTLSLFFTVLQDVPVR (19aa)
- WTGHNVTVVQR (11aa)
- LHKDNTTCYEFK (12aa)
- MLWEHNSTIIVMLTK (15aa)
- NPNNDQVFPNGTLAPSIPIWGGSWR (25aa)
- DACGNGTCR (9aa)
- EVNCSFPLFMNGISK (15aa)
- GPPGVNGTQGFQGCPGQR (18aa)
- THANGSIK (8aa)
- LGPYANTTK (9aa)
- QLINALQINNTAVGH (15aa)
- NALQINNTAVGHAL (14aa)
- EAGNITTDGYEIIGK (15aa)
- KINIDGSNYTIIK (13aa)
- MHINGSNVQVIHR (13aa)
- TCVSNCTASQFVCK (14aa)
- SLTQGSLIVGDLAPVNGTSQGK (22aa)
- FGTCSQICNNTK (12aa)
- FEVDSPVYNATWSASLK (17aa)
- FEVDSPVYNATWSASIK (17aa)
- GVTHINISGIK (11aa)
- LNGTDPIVAADSK (13aa)
Mass spectrometry observed peptide
-
- Free / Lactose
(avg mass : 2241.0506)
- Milk (UBERON_0001913)
-
- Free / Lactose
(avg mass : 2241.0506)
- Milk (UBERON_0001913)
-
- Free / Lactose
(avg mass : 2241.0506)
- Milk (UBERON_0001913)
-
- Free / Lactose
(avg mass : 2241.0506)
- Milk (UBERON_0001913)
-
- Free / Lactose
(avg mass : 2241.0506)
- Milk (UBERON_0001913)
-
- Free / Lactose
(avg mass : 2241.0506)
- Milk (UBERON_0001913)
-
- N-Linked / Complex
(avg mass : 2241.0506)
- Detailed structural analysis of asparagine-linked oligosaccharides of the nicotinic acetylcholine receptor from Torpedo californica. (1992 - Shoji H, Takahashi N, Nomoto H, Ishikawa M, Shimada I, Arata Y, Hayashi K) / Status : Reviewed
- The structure of the asparagine-linked sugar chains of bovine brain ribonuclease. (1990 - Katoh H, Ohgi K, Irie M, Endo T, Kobata A) / Status : Reviewed
- Ribonuclease, brain / Bos taurus
-
Acetylcholine receptor protein / Torpedo californica
- Undefined site
-
- N-Linked / Complex
(avg mass : 2241.0506)
- Carcinoma, Lewis Lung
- Structures of the alpha(1-3)-galactose-containing asparagine-linked glycans of a Lewis lung carcinoma cell subline resistant to Aleuria aurantia agglutinin: elucidation by 1H-NMR spectroscopy. (1991 - Debray H, Dus D, Wieruszeski J, Strecker G, Montreuil J) / Status : Reviewed
- Oligosaccharides at individual glycosylation sites in glycoprotein 71 of Friend murine leukemia virus. (1990 - Geyer R, Dabrowski J, Dabrowski U, Linder D, Schlter M, Schott H, Stirm S) / Status : Reviewed
-
Uncharacterized protein from Lung / Mus musculus
- Undefined site
- Envelope glycoprotein / Friend murine leukemia virus
-
- N-Linked / Complex
(avg mass : 2241.0506)
- Lung (UBERON_0002048) LL/2 (LLC1) (CVCL_4358)
- Seminal Fluid (UBERON_0006530)
- Thyroid (UBERON_0002046)
- Eveline (CVCL_A1LI)
- Carcinoma, Lewis Lung
- Structural characterization of the oligosaccharide chains of native and crystallized boar seminal plasma spermadhesin PSP-I and PSP-II glycoforms. (1999 - Nimtz M, Grabenhorst E, Conradt H, Sanz L, Calvete J) / Status : Reviewed
- Structure determination by 1H NMR spectroscopy of (sulfated) sialylated N-linked carbohydrate chains released from porcine thyroglobulin by peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase-F. (1991 - de Waard P, Koorevaar A, Kamerling J, Vliegenthart J) / Status : Reviewed
- Structures of the alpha(1-3)-galactose-containing asparagine-linked glycans of a Lewis lung carcinoma cell subline resistant to Aleuria aurantia agglutinin: elucidation by 1H-NMR spectroscopy. (1991 - Debray H, Dus D, Wieruszeski J, Strecker G, Montreuil J) / Status : Reviewed
- Analysis of N- and O-glycosidically bound sialooligosaccharides in glycoproteins by high-performance liquid chromatography with pulsed amperometric detection. (1990 - Honda S, Suzuki S, Zaiki S, Kakehi K) / Status : Reviewed
- Oligosaccharides at individual glycosylation sites in glycoprotein 71 of Friend murine leukemia virus. (1990 - Geyer R, Dabrowski J, Dabrowski U, Linder D, Schlter M, Schott H, Stirm S) / Status : Reviewed
-
Uncharacterized protein from Lung / Mus musculus
- Undefined site
- Major seminal plasma glycoprotein psp-i / Sus scrofa
- Major seminal plasma glycoprotein psp-ii / Sus scrofa
-
Thyroglobulin / Sus scrofa
- Undefined site
- Envelope glycoprotein / Friend murine leukemia virus
-
- N-Linked / Complex
(avg mass : 2241.0506)
- Plasma Membrane (GO_0005886)
-
Uncharacterized protein / Bos taurus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2241.0506)
- Zona Pellucida (UBERON_0000086)
-
Zona pellucida sperm-binding protein matrix / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2241.0506)
- Blood Serum (UBERON_0001977)
-
Acetylcholinesterase / Bos taurus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2241.0506)
- Milk (UBERON_0001913)
-
- N-Linked / Hybrid
(avg mass : 2241.0506)
- Milk (UBERON_0001913)
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-2-HS-glycoprotein / Homo sapiens
- Alpha-S1-casein / Homo sapiens
- Lactotransferrin / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- KDTRNESTQNCVVAEPEKM (19aa)
- KVCQDCPLLAPLNDTRV (17aa)
- RRTAGWNVPIGTLRPFLNWTGPPEPIEAAVARF (33aa)
- KQIGLYPVLVIDSSGYVNPNYTGRI (25aa)
- KYLGNATAIFFLPDEGKL (18aa)
- RTAGWNIPMGLLFNQTGSCKF (21aa)
- KSCHTAVDRTAGWNIPMGLLFNQTGSCKF (29aa)
- KWNNTGCQALPSQDEGPSKA (20aa)
-
- N-Linked / Hybrid
(avg mass : 2241.0506)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
-
- N-Linked / Hybrid
(avg mass : 2241.0506)
-
- N-Linked / Hybrid
(avg mass : 2241.0506)
- Primary Human Natural Killer Cells Retain Proinflammatory IgG1 at the Cell Surface and Express CD16a Glycoforms with Donor-dependent Variability. (2019 - Patel KR, Nott JD, Barb AW) / Status : Unreviewed
- Glycoproteomics: Identifying the Glycosylation of Prostate Specific Antigen at Normal and High Isoelectric Points by LC-MS/MS (2014 - Song E, Mayampurath A, Yu CY, Tang H, Mechref Y) / Status : Reviewed
- Low affinity immunoglobulin gamma Fc region receptor III-A (FcγRIIIa ) / Homo sapiens
- Prostate-specific antigen (psa-1) / Homo sapiens
- Prostate-specific antigen - high Pi isoform (psah) / Homo sapiens
- FHNESLISSQASSY (14aa)
- NKSVLLGR (8aa)
-
- N-Linked / Hybrid
(avg mass : 2241.0506)
-
- N-Linked / Hybrid
(avg mass : 2241.0506)
- Cerebellum (UBERON_0002037)
- Frontal Cortex (UBERON_0001870)
- Hippocampul formation (UBERON:0002421)
- Striatum (UBERON_0002345)
-
- N-Linked / Hybrid
(avg mass : 2241.0506)
-
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2241.0506)
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Mammary Gland (UBERON_0001911)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Urine (UBERON_0001088)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc"
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-?)[NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
- N-Linked / Complex / Gal(b1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Hybrid / Structure 9475
- N-Linked / Hybrid / Structure 10001
- N-Linked / Hybrid / Structure 10132
- N-Linked / Hybrid / Structure 10979
- N-Linked / Hybrid / Structure 11541
- N-Linked / Hybrid / Structure 11553
- N-Linked / Hybrid / Structure 11792
- Structural and functional characterization of SARS-CoV-2 RBD domains produced in mammalian cells (2021 - Christoph Gstöttner, Tao Zhang, Anja Resemann, Sophia Ruben, Stuart Pengelley, Detlev Suckau, Tim Welsink, Manfred Wuhrer, Elena Domínguez-Vega) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Acid ceramidase / Homo sapiens
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- Adipocyte enhancer-binding protein 1 / Homo sapiens
- Afamin / Homo sapiens
- Agrin / Homo sapiens
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-acid glycoprotein 2 / Homo sapiens
- Alpha-1-antichymotrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-2-HS-glycoprotein / Homo sapiens
- Alpha-2-macroglobulin / Homo sapiens
- Aminopeptidase n / Homo sapiens
- Angiopoietin-related protein 2 / Homo sapiens
- Angiotensin-converting enzyme / Homo sapiens
- Anoctamin-6 / Homo sapiens
- Antithrombin-III / Homo sapiens
- Apolipoprotein (a) / Homo sapiens
- Apolipoprotein B-100 / Homo sapiens
- Apolipoprotein D / Homo sapiens
- Asialoglycoprotein receptor 2 / Homo sapiens
- Attractin / Homo sapiens
- Basement membrane-specific heparan sulfate proteoglycan core protein / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Biglycan / Homo sapiens
- Bone morphogenetic protein 1 / Homo sapiens
- BRCA2-interacting transcriptional repressor EMSY / Homo sapiens
- C-type mannose receptor 2 / Homo sapiens
- C4b-binding protein alpha chain / Homo sapiens
- C4b-binding protein beta chain / Homo sapiens
- Cadherin-13 / Homo sapiens
- Calumenin / Homo sapiens
- Carboxypeptidase D / Homo sapiens
- CD166 antigen / Homo sapiens
- CD276 antigen / Homo sapiens
- CD44 antigen / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Clusterin / Homo sapiens
- Collagen alpha-1(VI) chain / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-2(VI) chain / Homo sapiens
- Collagen alpha-3(VI) chain / Homo sapiens
- Complement C2 / Homo sapiens
- Complement c4-a / Homo sapiens
- Complement C4-B / Homo sapiens
- Complement component C9 / Homo sapiens
- Complement factor b / Homo sapiens
- Complement factor h / Homo sapiens
- Complement factor H-related protein 1 / Homo sapiens
- Complement factor H-related protein 2 / Homo sapiens
- Complement factor H-related protein 4 / Homo sapiens
- Complement factor i / Homo sapiens
- Complement receptor type 1 / Homo sapiens
- Contactin-4 / Homo sapiens
- Corticosteroid-binding globulin / Homo sapiens
- Decorin / Homo sapiens
- Desmocollin-2 / Homo sapiens
- Desmoglein-2 / Homo sapiens
- Disintegrin and metalloproteinase domain-containing protein 15 / Homo sapiens
- Ectonucleoside triphosphate diphosphohydrolase 2 / Homo sapiens
- Endoplasmic reticulum aminopeptidase 2 / Homo sapiens
- Ephrin-A3 / Homo sapiens
- Ephrin-B2 / Homo sapiens
- Epidermal growth factor receptor / Homo sapiens
- Epithelial cell adhesion molecule / Homo sapiens
- Extracellular matrix protein 1 / Homo sapiens
- Fetuin-B / Homo sapiens
- Fibrillin-1 / Homo sapiens
- Fibrinogen beta chain / Homo sapiens
- Fibromodulin / Homo sapiens
- Fibronectin / Homo sapiens
- Golgi apparatus protein 1 / Homo sapiens
- Haptoglobin / Homo sapiens
- Heat shock 70 kDa protein 1-like / Homo sapiens
- Heat shock 70 kDa protein 1A / Homo sapiens
- Heat shock 70 kDa protein 1B / Homo sapiens
- Hemopexin / Homo sapiens
- Heparin cofactor 2 / Homo sapiens
- Histidine-rich glycoprotein / Homo sapiens
- Homeobox protein Hox-B3 / Homo sapiens
- IgGFc-binding protein / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Immunoglobulin heavy constant delta / Homo sapiens
- Immunoglobulin heavy constant gamma 4 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Immunoglobulin J chain / Homo sapiens
- Immunoglobulin superfamily containing leucine-rich repeat protein / Homo sapiens
- Immunoglobulin superfamily DCC subclass member 4 / Homo sapiens
- Immunoglobulin superfamily member 8 / Homo sapiens
- Inactive carboxypeptidase-like protein X2 / Homo sapiens
- Inactive tyrosine-protein kinase 7 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h1 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h2 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain H3 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain H5 / Homo sapiens
- Intercellular adhesion molecule 2 / Homo sapiens
- Interleukin-1 receptor-like 1 / Homo sapiens
- Interleukin-6 receptor subunit beta / Homo sapiens
- Kallistatin / Homo sapiens
- Kininogen-1 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Laminin subunit alpha-2 / Homo sapiens
- Laminin subunit alpha-4 / Homo sapiens
- Laminin subunit gamma-1 / Homo sapiens
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- Low affinity immunoglobulin gamma Fc region receptor III-B / Homo sapiens
- Lumican / Homo sapiens
- Lysosome membrane protein 2 / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Macrophage mannose receptor 1 / Homo sapiens
- Macrosialin / Homo sapiens
- Mesothelin / Homo sapiens
- Midasin / Homo sapiens
- Myelin protein P0 / Homo sapiens
- Myelin protein zero-like protein 1 / Homo sapiens
- N-acetylglucosamine-1-phosphotransferase subunits alpha/beta / Homo sapiens
- N-acetylmuramoyl-l-alanine amidase / Homo sapiens
- Neogenin / Homo sapiens
- Neural cell adhesion molecule 1 / Homo sapiens
- Neurofascin / Homo sapiens
- Neuronal cell adhesion molecule / Homo sapiens
- Olfactomedin-like protein 3 / Homo sapiens
- Periostin / Homo sapiens
- Plasma kallikrein / Homo sapiens
- Plasma protease c1 inhibitor / Homo sapiens
- Plasma serine protease inhibitor / Homo sapiens
- Plexin-B2 / Homo sapiens
- Podocan / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prolargin / Homo sapiens
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
- Prostaglandin F2 receptor negative regulator / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Protein AMBP / Homo sapiens
- Protocadherin-9 / Homo sapiens
- Receptor-type tyrosine-protein phosphatase C / Homo sapiens
- Receptor-type tyrosine-protein phosphatase F / Homo sapiens
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens
- Secreted frizzled-related protein 3 / Homo sapiens
- Selenoprotein P / Homo sapiens
- Semaphorin-6A / Homo sapiens
- Semaphorin-7A / Homo sapiens
- Serotransferrin / Homo sapiens
- Sex hormone-binding globulin / Homo sapiens
- Signal transducer CD24 / Homo sapiens
- Sparc / Homo sapiens
- Sulfhydryl oxidase 1 / Homo sapiens
- Tenascin / Homo sapiens
- Teneurin-2 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Tolloid-like protein 1 / Homo sapiens
- Tolloid-like protein 2 / Homo sapiens
- Transmembrane 9 superfamily member 3 / Homo sapiens
- Uromodulin / Homo sapiens
- Vascular cell adhesion protein 1 / Homo sapiens
- Vitronectin / Homo sapiens
- Von willebrand factor / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
- Cell adhesion molecule 4 / Mus musculus
- Complement C1q subcomponent subunit A / Mus musculus
- Hepatocyte cell adhesion molecule / Mus musculus
- Myelin-oligodendrocyte glycoprotein / Mus musculus
- Neural cell adhesion molecule L1 / Mus musculus
- Probable G-protein coupled receptor 158 / Mus musculus
- Protein disulfide-isomerase TMX3 / Mus musculus
- Thy-1 membrane glycoprotein / Mus musculus
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- DIENFNSTQK (10aa)
- LVPVPITNATLDQITGK (17aa)
- SIVLEPIYWNSSNSK (15aa)
- GCNDSDVLAVAGFALR (16aa)
- TAVNCSSDFDACLITK (16aa)
- TAVNCSSDFDACIITK (16aa)
- GSLEVNCSTTCNQPEVGGLETSLDK (25aa)
- SLPWNMTK (8aa)
- EIFVANGTQGK (11aa)
- WFSAGLASNSSWLR (14aa)
- APNPTNATTK (10aa)
- GCVLLSYLNETVTVSASLESVR (22aa)
- AFNSTLPTMAQMEK (14aa)
- ISPGKNATGMEVGWYR (16aa)
- IADAHIDRVENTTVYYIVIDVQESDCSVISR (31aa)
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- LNGTDVDTGMDFR (13aa)
- CIQANYSIMENGK (13aa)
- QTLFFNGTR (9aa)
- ENISDPTSPLR (11aa)
- SVQEIQATFFYFTPNKTEDTIFLR (24aa)
- SVQEIQATFFYFTPNK (16aa)
- AEMNGSK (7aa)
- TTENYPNAGLIMNYCR (16aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- AFITNFSMIIDGMTYPGIIK (20aa)
- AFITNF (6aa)
- AFITNFSMNIDGMTYPGIIK (20aa)
- ATVNDSGEYR (10aa)
- SSCGKENTSDPSIVIAFGR (19aa)
- TAFITNFTLTIDGVTYPGNVK (21aa)
- INISENYTISISNAR (15aa)
- VTVRPGESVMVNISAK (16aa)
- VLTLANFTTK (10aa)
- AQLLQGLGFNLTER (14aa)
- AQIIQGIGFNITER (14aa)
- IGHCPDPVIVNGEFSSSGPVNVSDK (25aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- TCNASQGFK (9aa)
- IAVQFGPGFSWIANFTK (17aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- TALFPDLLAQGNASLR (16aa)
- TFYWDFYTNR (10aa)
- ANIQFGDNGTTISAVSNK (18aa)
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- VCSNDNK (7aa)
- GAFISNFSMTVDGK (14aa)
- DLEITNATLQSEEDSR (16aa)
- DGSIVIHNLDYSDNGTFTCDVK (22aa)
- VIDFNCTTSSVSSALANTK (19aa)
- VIDFNCTTSSVSSAIANTK (19aa)
- LQNNENNISCVER (13aa)
- IQNNENNISCVER (13aa)
- GVNFNVSK (8aa)
- KLHINHNNLTESVGPLPK (18aa)
- LHINHNNLTESVGPLPK (17aa)
- TLNQSSDELQLSMGNAMFVK (20aa)
- TINQSSDEIQISMGNAMFVK (20aa)
- IGACNDTIQQIMEVFK (16aa)
- FGCEIENNR (9aa)
- LGACNDTLQQLMEVFK (16aa)
- NATYGYVIDDPDPDDGFNYK (20aa)
- GLSFDVSLEVSQGPGLLNDTK (21aa)
- EHEGAIYPDNTTDFQR (16aa)
- GTFTDCALANMTEQIR (16aa)
- QIEEFINQSSPFY (13aa)
- QLEEFLNQSSPF (12aa)
- VLTNQESPYQNHTGR (15aa)
- QQYNALLSNMSR (12aa)
- VCQDCPIIAPINDTR (15aa)
- KVCQDCPLLAPLNDTR (16aa)
- VCQDCPLLAPLNDTR (15aa)
- FINDTMAVYEAK (12aa)
- VYKPSAGNNSLYR (13aa)
- ILNQTADMLQLASK (14aa)
- LNLTTDPK (8aa)
- IYIDHNNITR (10aa)
- QQLQGVNVCGGR (12aa)
- HGIQYFNNNTQHSSLFTLNEVK (22aa)
- FVACQMELLHSNGSQR (16aa)
- VIGGNFTGSQR (11aa)
- CGNCSLTTLK (10aa)
- IVDVNITSEGK (11aa)
- AALAAFNAQNNGSNFQLEEISR (22aa)
- IYVIDGTQNDTAFVFPR (17aa)
- INATDADEPNTINSK (15aa)
- MVSHHNITTGATIINEQWIITTAK (24aa)
- MVSHHNLTTGATLINEQWLLTTAK (24aa)
- QVLFLDTVYGNCSTHFTVK (19aa)
- QIGLYPVLVIDSSGYVNPNYTGR (23aa)
- LPPGLLANFTLLR (13aa)
- SWPAVGNCSSAL (12aa)
- SWPAVGNCSSALR (13aa)
- SWPAVGNCSSAIR (13aa)
- SLTFNETYQDISELVYGAK (19aa)
- DFVNASSK (8aa)
- DGKPLLNDSR (10aa)
- FIHNENGANYSVTATR (16aa)
- AWGISVLNPNK (11aa)
- VPNNAIEGIENITAIYIQHNEIQEVGSSMR (30aa)
- ITYSIVQTNCSK (12aa)
- GITFQQNASSMCVPDQDTAIR (21aa)
- GLTFQQNASSMCVPDQDTAIR (21aa)
- GNITEYQCHQYITK (14aa)
- IADTNITSIPQGIPPSITEIHIDGNK (26aa)
- NTTGFK (6aa)
- FSIIGHASISCTVENETIGVWRPSPPTCEK (30aa)
- VEMANLLNLSER (12aa)
- YANITVDYLYNK (12aa)
- DFQHIINR (8aa)
- VVLHPNYSQVDIGLIK (16aa)
- VVIHPNYSQVDIGIIK (16aa)
- NISDGFDGIPDNVDAALALPAHSYSGR (27aa)
- FEDGVLDPDYPRNISDGFDGIPDNVDAALALPAHSYSGR (39aa)
- NVVNGSSPAIR (11aa)
- FHLANR (6aa)
- GCSSSTSVLLTLDNNVVNGSSPAIR (25aa)
- DPCSNVTCSFGSTCAR (16aa)
- YFYNGTSMACETFQYGGCMGNGNNFVTEK (29aa)
- IGNWSAMPSCK (11aa)
- VLSNNSDANLELINTWVAK (19aa)
- LGNWSAMPSCK (11aa)
- NPEAPLNVSR (10aa)
- IININPNK (8aa)
- LVAIAVIDEKNTSLEHTR (18aa)
- VVGVPYQGNATAIFIIPSEGK (21aa)
- IGISFNSISAVDNGSIANTPHIR (23aa)
- VVGVPYQGNATALFILPSEGK (21aa)
- MIENGSISFIPTIR (14aa)
- YLGNATAI (8aa)
- YIGNATAIFFIPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- ERPPTFLTPEGNASNK (16aa)
- NETYQLFLSYSSK (13aa)
- LNCSVPGDSHFYFNILQAVTDVIR (24aa)
- IVIDPSGSMNIYIVIDGSDSIGASNFTGAK (30aa)
- IVLDPSGSMNIYLVLDGSDSIGASNFTGAKK (31aa)
- IIAPAYFIIGGNQSGEGCVITR (22aa)
- NVSVAEGK (8aa)
- NMTIDGK (7aa)
- LNAENNATFYFK (12aa)
- GFSTQVLLGDVYQSPCTMAQRPQNFNSSAR (30aa)
- INAENNATFYFK (12aa)
- LSSLEYLDLSSNNLSR (16aa)
- ACPLDPATNK (10aa)
- DGFDISGNPWICDQNLSDLYR (21aa)
- NATGDYK (7aa)
- IYPGVDFGGEEINVTFVK (18aa)
- FQAFANGSLLIPDFGK (16aa)
- IIQVVYIHSNNITK (14aa)
- LHSNNITK (8aa)
- INGTQICPN (9aa)
- FPNIT (5aa)
- RFPNIT (6aa)
- CHLNNSECMPIK (12aa)
- VVNEMCPNITR (11aa)
- NISSEEK (7aa)
- VGQLQLSHNLSLVILVPQNLK (21aa)
- MINTSSIIEQINEQFNWVSR (20aa)
- VQPFNVTQGK (10aa)
- AGIQAFFQVQECNK (14aa)
- AGLQAFFQVQECNK (14aa)
- KVSCPIMPCSNATVPDGECCPR (22aa)
- VSCPIMPCSNATVPDGECCPR (21aa)
- NCTSISGDLHILPVAFR (17aa)
- LNITCESSK (9aa)
- NATVVWMK (8aa)
- IEPVHIQIQCMSQEQIAQVAANATK (25aa)
- LEPVHLQLQCMSQEQLAQVAANATK (25aa)
- TLLNASR (7aa)
- LANLTQGEDQYYLR (14aa)
- IANITQGEDQYYIR (14aa)
- GNTTTLISENGHAADTLTATNFR (23aa)
- TSMGLPVATLQQLEAAAVNVCNQTWAQLQAR (31aa)
- ALQAVYSMMSWPDDVPPEGWNR (22aa)
- SHLQNYTVNATK (12aa)
- LDVDQALNR (9aa)
- ANYTILK (7aa)
- GTAGNAIMDGASQIMGENR (19aa)
- YRGTAGNALMDGASQLMGENR (21aa)
- ENITAPGSDSAVFFEQGTTR (20aa)
- ENLTAPGSDSAVFFEQGTTR (20aa)
- RQDVNITVATVPSWIK (16aa)
- AVNITSENLIDDVVSLIR (18aa)
- DPEIEMSGGLVNGSSVTVSCK (21aa)
- NSTIPTK (7aa)
- NYTDCTSEGR (10aa)
- CGIVPVIAENYNK (13aa)
- CGLVPVLAENYNK (13aa)
- CGLVPVLAENYNKSDNCEDTPEAGYFAVAVVK (32aa)
- HIPGLIHNMTAR (12aa)
- AIPQPQNVTSIIGCTH (16aa)
- YVQNGTYTVK (10aa)
- APQHVVNHLPPYTNVSLK (18aa)
- GETASIICNISVR (13aa)
- SIPACVPWSPYLFQPNDTCIVSGWGR (26aa)
- VPGNVTAVLGETLK (14aa)
- NGSAAMCHFTTK (12aa)
- IIISPEENVTITCTAENQIER (21aa)
- GFGVAIVGNYTAALPTEAALR (21aa)
Source
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2241.0506)
Reported glycosite
- N-Linked / Hybrid
(avg mass : 2241.0506)
Source
Reported glycosite
- N-Linked / Hybrid
(avg mass : 2241.0506)
Reported glycosite
- N-Linked / Hybrid
(avg mass : 2241.0506)
Reference
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Hybrid
(avg mass : 2241.0506)
Reported glycosite
- N-Linked / Hybrid
(avg mass : 2241.0506)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Hybrid
(avg mass : 2241.0506)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Hybrid
(avg mass : 2241.0506)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2241.0506)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2241.0506)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2241.0506)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2241.0506)
Source
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2241.0506)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2241.0506)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2241.0506)
Source
Reported glycosite
- Free / Lactose
(avg mass : 2241.0506)
Source
Reported glycosite
- Free / Lactose
(avg mass : 2241.0506)
Source
Reported glycosite
- Free / Lactose
(avg mass : 2241.0506)
Source
Reported glycosite
- Free / Lactose
(avg mass : 2241.0506)
Source
Reported glycosite
- Free / Lactose
(avg mass : 2241.0506)
Source
Reported glycosite
- Free / Lactose
(avg mass : 2241.0506)